Regarding “Thrombolysis of occluded infrainguinal vein grafts: Predictors of outcome”  by unknown
192 Letters to the Editors
cedures is premature and might lead to an additional
threat to many extremities.
Markus A. Enzler, MD
Gefasschirurg EBSQ, Chirurg FMH
GefassZentrum Hirslanden
Witellikerstrasse 40
8029 Zurich, Switzerland
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Reply
10 the Editors:
I am grateful to Dr. Enzler for calling our attention to
his interesting work ofnearly two decades ago. It has long
been my belief, along with that of Dr. Enzler, that higher
flow velocities in small-diameter prostheses would yield
better results. His work, ofwhich I was not aware, strong-
ly shows that.
On the other hand, Dr. Enzler questions the results of
the multicenter randomized study. Although puzzling, the
fact is that the data are the data. Cox proportional hazards
regression analysis shows that the patency rate in larger-
diameter (7 to 8 mm) grafts (hazards ratio, 4.15) is supe-
rior to that in smaller-caliber grafts (5 to 6 mm). Dr.
Enzler should also read carefully what we said about it in
the paper. Most patients who undergo these short above-
knee reconstructions have fairly good-sized arteries, so the
size mismatch may not be actually as great as one would
suppose. And like Dr. Enzler, I usually size the graft
roughly to the size of the distal artery. The study group is
continuing to look at this interesting finding. But for the
moment, the data about graft size pertains to the final
statement in the abstract: "graft size should be carefully
considered in patients who undergo this operation."
William M. Abbott, MD
Department ofVascular Surgery
Massachusetts General Hospital
15 Parkman St., WAC 458
Boston, MA 02114
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Regarding "Thrombolysis of occluded infrainguinal
vein grafts: Predictors of outcome"
To the Editors:
I was pleased to read the recent report by Nackman and
colleagues on thrombolysis of occluded infrainguinal vein
grafts (J Vasc Surg 1997;25:1023-32), which demonstrated
the importance ofgraft age (>12 months) in selecting grafts
that would have a superior 2-year patency rate after lysis.
The similarity oftheir format and results to the paper I pre-
sented at the 1995 meeting of the Society for Clinical
Vascular Surgery and published in the American Journal of
Sut;gery1 is striking, but apparently it was never reviewed by
the authors nor referenced in their bibliography.
Their criticism ofprior publications because of insuffi-
cient follow-up and failure to independently analyze
results of different graft materials is generally valid.
However, our report of 61 thrombosed infrainguinal
bypass grafts included 48 vein grafts (36 saphenous, 12
alternative), which were analyzed separately and had a 26%
5-year secondary patency rate. We demonstrated that graft
age greater than 10 months had a very significant effect in
improving late patency rates by univariate and multivariate
analysis. The relative risk of occlusion for grafts less than
10 months old was 1.58 (p < 0.047), similar to the results
in the present report of 2.4 (p < 0.02) for grafts less than
12 months old.
Most importantly, the 5-year secondary patency rate
of 36 saphenous vein grafts was 45% if the grafts were
greater than 10 months old but only 21%if they were less
than 10 months old (p < 0.008), suggesting that throm-
bolytic therapy for intact saphenous vein grafts (as
opposed to alternative vein or polytetrafluoroethylene
grafts) can achieve patency rates that are competitive with
the results of secondary bypass procedures, especially if
another saphenous vein is not available. To emphasize this
point, a review of 161 secondary bypass grafts from my
own data showed 5-year secondary patency rates of 67%,
50%, and 31% for saphenous vein, alternative vein, and
polytetrafluoroethylene grafts, respectively.
Although I am disappointed that the authors over-
looked our larger and longer series that proved the same
point, I am pleased to bring this experience to the attention
of the authors and the readers of the Journal of Vascular
Sut;gery to reenforce these important observations.
Henry D. Berkowitz, MD
Allegheny University Hospitals
Broad & Vine, Mail Stop 468
Philadelphia, PA 19102-1192
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